Page last updated: 2024-08-24

topotecan and cyclin d1

topotecan has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asano, T; Horiguchi, A; Ito, K; Sato, A; Sumitomo, M	1

Other Studies

1 other study(ies) available for topotecan and cyclin d1

Article	Year
Antitumor effect of suberoylanilide hydroxamic acid and topotecan in renal cancer cells. Oncology research, 2011, Volume: 19, Issue:5 Topics: Acetylation; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Kidney Neoplasms; Topotecan; Vorinostat	2011

Article

Year

Antitumor effect of suberoylanilide hydroxamic acid and topotecan in renal cancer cells.

Oncology research, 2011, Volume: 19, Issue:5

Topics: Acetylation; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Kidney Neoplasms; Topotecan; Vorinostat

2011